We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PPBT market cap is 5M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.75M | -6.27M | -4.47M | -3.19M | -2.13M |
| Net Income | -5.04M | -4.83M | -3.76M | -2.41M | -663k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.6M | 1.18M | 66k | 0 | 0 |
| Operating Income | -7.16M | -12.61M | -17.93M | -22.6M | -22.27M |
| Net Income | -5.85M | -28M | -18.38M | -21.67M | -19.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.27M | 44.3M | 39.86M | 36.07M | 35.11M |
| Total Liabilities | 6.55M | 10.01M | 8.77M | 6.69M | 5.64M |
| Total Equity | 38.72M | 34.3M | 31.09M | 29.38M | 29.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.72M | 83.8M | 70.2M | 54.62M | 44.3M |
| Total Liabilities | 3.86M | 4.05M | 5.09M | 7.52M | 10.01M |
| Total Equity | 10.86M | 79.75M | 65.11M | 47.1M | 34.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.94M | -19.93M | -5.08M | -9.06M | -12.35M |
| Investing | 13.81M | 13.88M | 312k | 399k | 471k |
| Financing | 1.2M | 5.45M | 268k | 701k | 2.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.58M | -12.09M | -15.25M | -16.74M | -19.93M |
| Investing | -449k | -49.6M | 13.41M | 19.91M | 13.88M |
| Financing | 5.23M | 68.49M | 1.51M | 1.11M | 5.45M |
| Market Cap | 5M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 1.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3.6 (51.43%) |
| Company Name | Purple Biotech Ltd |
| Address |
4 oppenheimer street rehovot, center 7670104 |
| Website | https://www.purple-biotech.com |
| Industry | arrange trans-freight, cargo (4731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
